All News

Found 22,127 articles

• Centocor, Inc. Phase 3 Data Show New Anti-TNF, Golimumab, Significantly Improved Arthritis, Skin and Nail Manifestations in Patients with Psoriatic Arthritis

  11/8/2007

• Medarex, Inc. Announces Presentations on UltiMAb(R) Antibodies at 71st Annual Meeting of the American College of Rheumatology

  11/8/2007

• Amgen Strengthens Warnings on Anemia Drug Labels

  11/8/2007

• Amgen Announces Updates to the U.S. Prescribing Information for ESAs

  11/8/2007

• MAP Pharmaceuticals, Inc. Reports Third Quarter Financial Results

  11/8/2007

• Vion Pharmaceuticals Reports 2007 Third Quarter and Nine-Month Results

  11/8/2007

• Vapotherm Inc. Earns Achievement Award from U.S. Department Of Commerce

  11/8/2007

• Johnson & Johnson to Present at the Credit Suisse 2007 Healthcare Conference

  11/7/2007

• Centocor, Inc.'s REMICADE(R) Becomes First Anti-TNF Biologic Therapy to Treat One Million Patients Worldwide

  11/6/2007

• ConforMIS Names Vice President of Implant Engineering

  11/6/2007

• TorreyPines Therapeutics, Inc. to Present at the JMP Securities Healthcare Focus Conference

  11/6/2007

• Forest Laboratories, Inc. and Cypress Bioscience Inc. to Host Webcast to Discuss Clinical Data Presentations for Milnacipran

  11/5/2007

• MedImmune, Inc. Announces Seven Key Promotions and New Hires

  11/5/2007

• Cypress Bioscience Inc. to Present at CIBC World Markets 18th Annual Healthcare Conference

  11/5/2007

• KOSAN Biosciences, Inc. to Present at November Healthcare Conferences

  11/2/2007

• Boston Scientific Corporation Says Jury Finds It Infringed Johnson & Johnson Unit Patent

  11/1/2007

• Abbott Laboratories Suffers as Johnson & Johnson Clot Woes, Stent Review Nears

  11/1/2007

• Boston Scientific Corporation Announces Verdict in Cordis Corporation Litigation

  11/1/2007

• DRAXIS Health, Inc. Reports Third Quarter Results

  11/1/2007

• Millennium Pharmaceuticals, Inc. (Cambridge, Massachusetts) Reports Outstanding Third-Quarter Results

  11/1/2007